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Abstract
Background: The optimal management of acute pancreatitis remains controversial and current treat-
ment protocols vary in degrees of medical and surgical management. Our group has previously shown in
population-based studies that high-volume (HV) hospitals have lower rates of in-hospital mortality after
pancreatectomy. We sought to examine if a similar mortality benefit exists for patients admitted with acute
pancreatitis.
Methods: Using the Nationwide Inpatient Sample (NIS), we examined discharge records for all adult
admissions during 1998–2006 with a primary diagnosis of acute pancreatitis of any aetiology. Unique
hospital identifiers were used to divide hospital volumes into equal thirds based on the number of
admissions for acute pancreatitis per year (lowest tertile [low volume, LV] 64 admissions/year; medium
tertile [medium volume, MV] 65–117 admissions/year; highest tertile [high volume, HV] 118 admissions/
year). Covariates included patient demographics, hospital characteristics and patient co-morbidities
using the Elixhauser index. Adjusted mortality represented the primary outcome measure and adjusted
length of stay (LOS) and total charges were considered secondary measures.
Results: There were 416 489 primary admissions for acute pancreatitis during the study period.
In-hospital mortality for the cohort amounted to 1.6% (n = 6446). Hospital admissions for acute pancre-
atitis increased over the study period (P < 0.0001). High-volume hospitals tended to be large (82%), urban
(99%) teaching (59%) centres (P < 0.0001), which cared for patients with more co-morbidities (35.9% of
patients at HV hospitals vs. 29.1% at LV hospitals had at least three co-morbidities; P < 0.0001).
Low-volume centres appeared more likely to perform pancreatic procedures than HV hospitals (odds ratio
[OR] 1.50, 95% confidence interval [CI] 1.32–1.70). Patients at HV hospitals had a lower likelihood of a
prolonged adjusted LOS compared with those at LV (OR 0.75, 95% CI 0.71–0.79) or MV (OR 0.82, 95%
CI 0.79–0.85) hospitals. After adjusting for patient and hospital factors, there was an in-hospital mortality
benefit associated with being treated at an HV centre (OR 0.70, 95% CI 0.63–0.77). The decision to
operate on a given patient did not alter the mortality benefit of the HV hospital.
Conclusions: Rates of admissions for acute pancreatitis in the USA are increasing. High annual hospital
volume of acute pancreatitis cases confers a shorter LOS, lower adjusted mortality and a lower likelihood
of pancreatic procedure for patients admitted with acute pancreatitis. Although HV hospitals were less
likely than MV or LV centres to perform pancreatic procedures, the role of surgery remains unclear. Further
studies should examine other possible reasons for this mortality benefit, such as the availability of
specialists, the quality of critical care facilities and the timing of operative intervention.
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Introduction
Hospital volume has been associated with improved patient out-
comes in several past studies.1–4 These studies, however, mostly
dealt with complex surgical procedures and cancer resections. Our
group has previously shown that high-volume (HV) hospitals
have better outcomes after pancreatectomy and liver resection.4,5
Few, if any, studies have shown the potential benefits of HV treat-
ment in medical diagnoses such as acute pancreatitis. One study
examining hospital volume and acute liver failure failed to show a
mortality benefit at HV hospitals,6 whereas another, examining
inflammatory bowel disease (IBD), showed an outcome benefit in
surgical IBD patients only.7 This may reflect a lack of definable
outcomes or failure to attribute differences in care to a specific
intervention.
Given the rising incidence and high cost of acute pancreatitis,
and the lack of studies examining volume–outcome benefits in
medical diagnoses, the identification of a volume–outcome rela-
tionship in acute pancreatitis may have important implications
for future policy and the referral of complicated cases. We sought
to examine the relationship between hospital admissions and
improved outcomes in the care of patients with acute pancreatitis
on a national level.
Materials and methods
We used the Nationwide Inpatient Sample (NIS) for the years
1998–2006 to extract data for all patients presenting with a
primary diagnosis of acute pancreatitis (ICD-9-CM 577.0). Our
methods were as previously described.4,8 The NIS is the largest
national, all-payer hospital inpatient care database in the USA. It
is supported by the Healthcare Cost and Utilization Project
(HCUP) and contains all-payer discharge information for 100%
of patient discharges from participating hospitals. Data exist for
approximately seven million hospital discharges per year from a
stratified sample of 20% of non-federal US community hospitals
in participating states, including academic and specialty hospitals.
The NIS contains hospital-level information obtained from a
direct link to the American Hospital Association’s (AHA) annual
survey of hospitals, which includes hospital type (teaching, non-
teaching) and geographic region (northeast, west, south, midwest
as defined by the US Census Bureau). Each record in the NIS
represents a single hospital discharge and includes a unique
identifier.
The study was reviewed by the University of Massachusetts
Institutional Review Board (IRB) as appropriate for exemption
from IRB oversight as no personal identifiers were used in the
registry data.
Study population
Diagnosis and procedures were identified by the Clinical Modifi-
cation of the International Classification of Diseases, 9th Revision
(ICD-9-CM) diagnostic and procedural codes. All patients with a
primary diagnosis of acute pancreatitis (ICD-9-CM 577.0) were
identified. Patients under the age of 18 years were excluded from
the dataset.
Hospital volume
Unique hospital identifiers were used to determine the number of
cases of acute pancreatitis seen at each individual hospital. Hos-
pital identifiers remain the same throughout the different years of
the NIS and are linked to hospital characteristics via the AHA
annual survey as described above. Each record in the NIS is con-
sidered as a single unit assigned to a specific hospital. As a result of
NIS sampling, it is possible for a hospital to be included in a
particular year and not included the following year. Additionally,
a hospital’s volume may change yearly. Therefore, hospital volume
was calculated on an annual basis. Extrapolation of the dataset
using institutional weighting was not performed. Hospital volume
was divided into equal thirds based on the number of cases of
acute pancreatitis admitted per year (lowest tertile [low volume,
LV] 64 admissions/year; middle tertile [medium volume, MV]
65–117 admissions/year; highest tertile [high volume, HV] 118
admissions/year). All data were analysed by volume tertile.
Variables
Patient demographics and hospital characteristics were captured
within the NIS. Age was maintained as a continuous variable. Race
was divided into White, Black, Hispanic or Other, which included,
but was not limited to, Asians, Pacific Islanders and Native Ameri-
cans. Income was categorized in four quartiles. Income bracket
was a categorical variable derived from the median household
income in the patient’s residential zip code. For 1998–2002, these
quartiles were defined based on 1999 demographics such that the
maximum of the first quartile was 150% of the poverty level, and
the national median income represented the boundary between
the second and third quartiles. For 2003–2006, the quartiles were
adjusted annually to divide patients equally, so that the national
median income again represented the boundary between the
second and third quartiles. Payer type was divided into four
groups: Medicare, Medicaid, private insurance, and other. Hospi-
tal size was reported in tertiles, as small, medium and large. The
cut-off for each tertile differed depending on the region, location
(rural/urban) and teaching status of the hospital, so that hospitals
were divided approximately equally. Hospital region, location and
teaching status were also examined individually.
For purposes of risk adjustment, co-existing co-morbidity was
compiled to create an Elixhauser co-morbidity index.9 This index
identifies 29 disease entities that are considered true co-morbid
diseases associated with adverse outcomes in hospitalized
patients. Patients were given a score of 0, 1, 2 or 3 based on the
number of co-morbidities.
Outcomes
The primary endpoint examined in this study was in-hospital
mortality. Mortality was defined as death from any cause prior to
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discharge. Secondary outcome measures included prolonged
length of stay (LOS) and total hospital charges. Prolonged LOS
was defined as any stay that was greater than that of the 90th
percentile of the whole cohort, which was 8 days. A categorical
value was then assigned according to whether or not the hospital
stay exceeded that of the 90th percentile. This captured compli-
cated cases and long hospitalizations and reflected atypical dis-
charge patterns.
In order to examine if access to and performance of pancreatic
procedures affected outcomes, several pancreatic procedures were
identified (Table 1). A dichotomous variable was created to convey
any pancreatic procedure performed and was subsequently analy-
sed as both an outcome and a covariate.
Statistical analysis
Data were analysed using sas Version 9.1 (SAS Institute, Inc.,
Cary, NC, USA). Categorical variables and outcomes were tested
for statistical significance with chi-square analysis. Continuous
variables and outcomes were tested using anova. Temporal trends
were assessed using the Cochrane–Armitage trend test. Statistical
significance was defined by P < 0.05.
Univariate predictor variables with a P < 0.10 were included in
the multivariate logistic regression analysis. Logistic regression
was used to analyse categorical outcomes while adjusting for cova-
riates. Covariates included age, gender, race, insurance type, high
income bracket, co-morbidities and hospital characteristics. The
performance of a pancreatic procedure was analysed as both a
covariate for mortality and an individual outcome. A Hosmer–
Lemeshow goodness-of-fit test was performed to confirm the final
models. All results in the regression model were represented by an
odds ratio (OR) and 95% confidence interval (CI). All regression
models were performed separately.
Results
During 1998–2006, a total of 416 489 discharges with a primary
diagnosis of acute pancreatitis were captured in the NIS. The
number of cases of acute pancreatitis increased with each succes-
sive year in this time period, from 36 510 cases in 1998 to 51 895
cases in 2006 (Fig. 1) (P < 0.0001).
Demographic characteristics of patients admitted with acute
pancreatitis are shown in Table 2, broken down into the three
volume groups. When compared with the MV and LV hospitals,
HV hospitals tended to be large (82.2% vs. 56.1% vs. 32.7%,
respectively), urban (98.9% vs. 89.1% vs. 58.6%, respectively),
teaching (58.5% vs. 36.7% vs. 13.8%, respectively) centres (P <
0.0001). High-volume hospitals treated Black patients more com-
monly than either MV or LV hospitals (22.1% vs. 19.0% vs. 13.7%,
respectively). High-volume hospitals also treated more patients
with three or more co-morbidities (35.9% vs. 33.4% vs. 29.1%,
respectively).
Unadjusted, univariate outcomes are shown in Table 3. The
overall in-hospital mortality for the cohort was 1.6% (n = 6446).
There was a significant mortality difference according to volume
among the providers of care for acute pancreatitis (P < 0.0001).
Patients in HV and MV hospitals seemed to have a slightly longer
LOS than those in LV hospitals, with 12.0% of patients at HV
hospitals experiencing a prolonged LOS vs. 8.9% of patients at LV
hospitals. Additionally, on univariate analysis, HV and MV hos-
pitals had higher mean total charges ($24 100 at HV hospitals)
compared with LV hospitals ($16 600). Overall, only 0.93% of
patients in the overall cohort underwent a pancreatic procedure
during the inpatient stay. The most commonly performed pan-
creatic procedures were endoscopic retrograde cholangiopancre-
atography (ERCP) (n = 18 196) and pancreatotomy (n = 1627).
Prior to any adjustment, a larger percentage of patients at HV
hospitals underwent a pancreatic procedure than at MV or LV
hospitals (1.19% vs. 1.04% vs. 0.54%, respectively).
Results of the multivariate analysis for in-hospital mortality
using logistic regression are shown in Table 4. Factors associated
with higher odds of mortality included increasing age (OR 1.04,
95% CI 1.04–1.05), having a single co-morbidity (OR 1.72, 95%
CI 1.48–1.99), being treated at a teaching hospital (OR 1.43, 95%
CI 1.34–1.53), being treated at an urban hospital (OR 1.50,
95% CI 1.35–1.53), and being treated at a large hospital (OR 1.61,
95% CI 1.45–1.80). After adjusting for covariates, there was an
independent in-hospital mortality benefit for patients treated at
HV hospitals compared with LV hospitals (OR 0.70, 95% CI 0.63–
Table 1 Pancreatic procedures and corresponding ICD-9-CM codes
Pancreatic procedure ICD-9-CM
code
Endoscopic retrograde cholangiopancreatography 51.10
Pancreatotomy 52.0
Excision of pancreatic lesion 52.2
Marsupialization of pancreatic cyst 52.3
Internal drainage of pancreatic cyst 52.4
Partial pancreatectomy 52.5
Total pancreatectomy 52.6
Radical pancreaticoduodenectomy 52.7
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Figure 1 Number of admissions for acute pancreatitis in the USA by
year (total n = 416 489)
HPB 393
HPB 2009, 11, 391–397 © 2009 International Hepato-Pancreato-Biliary Association
0.77) and HV hospitals compared with MV hospitals (OR 0.77,
95% CI 0.72–0.83). Similar analysis was performed for the
outcome of prolonged LOS. High-volume hospitals showed a sig-
nificantly lower likelihood of prolonged LOS compared with LV
hospitals (OR 0.77, 95% CI 0.74–0.80) and MV hospitals (OR
0.83, 95% CI 0.81–0.86).
Multivariate logistic regression adjusting for covariates was also
performed with the performance of any pancreatic procedure as
an outcome variable. Low-volume centres appeared to be more
likely to perform pancreatic procedures than HV hospitals (OR
1.50, 95% CI 1.32–1.70). As ERCP was the most common proce-
dure performed, we then used multivariate logistic regression to
examine the performance of ERCP alone and other pancreatic
procedures separately. Low-volume centres were independently
more likely to perform ERCP (OR 1.22, 95% CI 1.15–1.29) and
more likely to perform a pancreatic procedure other than ERCP
Table 2 Patient demographics and hospital characteristics of admissions with a primary diagnosis of acute pancreatitis
Demographic Low-volume centre
(n = 137 497)
Medium-volume centre
(n = 139 624)
High-volume centre
(n = 139 368)
P-value
Female gender 50.0% 49.5% 49.1% 0.0001
Race <0.0001
White 72.3% 64.1% 59.7%
Black 13.7% 19.0% 22.1%
Hispanic 9.1% 12.1% 14.3%
Other 4.9% 4.8% 3.9%
Primary payer <0.0001
Medicare 36.1% 33.2% 30.7%
Medicaid 14.1% 13.9% 14.4%
Private insurance 34.4% 37.7% 37.3%
Other 15.5% 15.3% 17.7%
High income bracket 19.7% 30.0% 28.1% <0.0001
Elixhauser co-morbidity score <0.0001
0 19.6% 17.3% 16.1%
1 26.4% 24.3% 23.2%
2 24.9% 25.0% 24.9%
3 29.1% 33.4% 35.9%
Teaching hospital 13.8% 36.7% 58.5% <0.0001
Urban hospital 58.6% 89.1% 98.9% <0.0001
Hospital size by beds <0.0001
Small 30.6% 10.6% 1.4%
Medium 36.7% 33.4% 16.4%
Large 32.7% 56.1% 82.2%
Hospital region <0.0001
Northeast 18.0% 16.7% 14.5%
Midwest 25.2% 19.8% 19.0%
South 38.3% 44.9% 46.7%
West 18.4% 18.7% 19.8%
Table 3 Patient outcomes for admissions with a primary diagnosis of acute pancreatitis
Outcome Low-volume centre Medium-volume centre High-volume centre P-value
Mortality 1.4% 1.7% 1.5% <0.0001
Length of stay (median), days 5.3 (4) 6.0 (4) 6.1 (4) <0.0001
Prolonged length of stay 8.9% 11.7% 12.0% <0.0001
Total charges $16 600 $23 600 $24 100 <0.0001
Any pancreatic procedure 0.54% 1.04% 1.19% <0.0001
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(OR 1.50, 95% CI 1.32–1.72). When the performance of any pan-
creatic procedure was added as a covariate to the multivariate
logistic regression for in-hospital mortality, the mortality benefit
associated with HV hospitals did not change.
Discussion
In this study of the NIS, we confirmed that annual admissions for
acute pancreatitis are increasing in the USA. We found that
patients admitted with acute pancreatitis have better outcomes
when admitted to hospitals with high volumes of acute pancre-
atitis cases. Significant demographic differences exist between HV
hospitals and MV and LV hospitals, at both the patient and hos-
pital levels. After adjusting for these differences using multivariate
logistic regression, care at an HV hospital resulted in a significant
in-hospital mortality benefit compared with care at an MV or LV
hospital. Care at an HV hospital also reduced the likelihood of a
prolonged LOS. After adjusting for covariates in a multivariate
logistic regression, LV centres were found to be more likely to
perform pancreatic procedures than HV centres. The perfor-
mance of these procedures did not alter the mortality benefit
associated with HV hospitals. Univariate analysis of total charges
seemed to indicate that HV centres spend more per case than LV
centres.
Previous studies have shown that the incidence of acute pan-
creatitis has increased in the USA and internationally.10–13 Our
study of the NIS confirms these temporal trends and extends the
existing data on acute pancreatitis by analysing outcomes based
on hospital volume and assessing the impact on patient outcomes
of pancreatic procedures. Increasing numbers of admissions will
have significant impact on future health care expenditures and
resources. Optimizing both the standard of care and the utiliza-
tion of resources should be important priorities in future policy
planning.
We have shown a clear and important relationship between
hospital volume and outcomes in acute pancreatitis. Birkmeyer
et al. previously showed that high hospital volume was associated
with various benefits in relation to surgical procedures, including
heart and lung surgery and abdominal cancer resections.1–3
Birkmeyer et al. went on to show the benefits associated with
individual surgeon volume.14 However, few, if any, studies have
examined the hospital volume benefit as it relates to a medical
diagnosis. Outcome benefits attributable to high hospital volume
have been shown for acute myocardial infarction,15 HIV/AIDS,16
and surgical IBD patients.7 For acute pancreatitis, our results show
a clear, risk-adjusted outcome benefit at HV hospitals that holds
true over a significant period of time.
The initial results of our univariate analysis of outcomes indi-
cated that HV hospitals had an overall low mortality rate of 1.5%,
a higher percentage of patients with a prolonged LOS, and a
higher percentage of patients undergoing pancreatic procedures
compared with LV centres. However, the significant demographic
differences at both the patient and hospital level between the
different hospital volume groups made it necessary to attempt to
adjust for these differences using multivariate analysis. A previous
study examining hospital volume effects on acute liver failure did
not show a mortality benefit at HV hospitals, but did show that
higher-volume hospitals tended to treat sicker patients.7 Our
results also indicate that HV hospitals treat a higher percentage of
Black and Hispanic patients, and a higher proportion of patients
with multiple co-morbidities. These disparities can result in con-
founding, which may explain the findings of our initial univariate
analysis.
The hospital volume benefit in outcomes seen in surgical
procedures makes clinical sense. Surgical specialization,17 mul-
tidisciplinary care,18 and surgeon experience19 have been shown to
independently improve patient outcomes after surgery. Higher-
volume hospitals may be more likely to offer such services. A
previous study showed disparities in access to liver resection
among different hospital volume groups, with higher-volume
hospitals providing more procedures.20 Given that acute
Table 4 Odds ratios of mortality in 416 489 admissions with a
primary diagnosis of acute pancreatitis
Factor Odds ratio 95% confidence
interval
Age 1.04 1.04–1.05
Female gender 0.74 0.69–0.78
Race
White Reference
Black 0.80 0.73–0.87
Hispanic 0.85 0.76–0.94
Other 0.82 0.71–0.96
Primary payer
Medicare Reference
Medicaid 1.02 0.91–1.15
Private insurance 0.83 0.76–0.91
Other 0.75 0.66–0.86
Elixhauser co-morbidity score
0 Reference
1 1.72 1.48–1.99
2 2.57 2.24–2.96
3 3.56 3.11–4.08
Teaching hospital 1.43 1.34–1.53
Urban hospital 1.50 1.35–1.53
Hospital size by beds
Small Reference
Medium 1.26 1.13–1.40
Large 1.61 1.45–1.80
Hospital volume
Low Reference
Medium 0.90 0.83–0.98
High 0.70 0.63–0.77
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pancreatitis may require both medical and surgical care, we specu-
lated that access to pancreatic procedures may explain the volume
benefit seen at HV hospitals. Initial univariate analysis of out-
comes (Table 3) indicates that a higher percentage of patients
underwent a pancreatic procedure at HV hospitals than at LV or
MV hospitals. However, these results are difficult to interpret
because of the demographic differences between patient popula-
tions at HV, MV and LV centres. After adjusting for patient and
hospital factors using multivariate analysis, LV hospitals are found
to be actually more likely to perform pancreatic procedures than
HV hospitals. Furthermore, the performance of pancreatic proce-
dures did not alter the mortality benefit associated with care at HV
centres. This is an interesting finding because it indicates that LV
hospitals, despite treating fewer Black and Hispanic patients, and
patients with fewer co-morbidities, are seemingly more likely to
perform pancreatic procedures, despite a higher likelihood of
in-hospital mortality overall.
The true mechanism of the volume benefit in our study
remains unclear and is most likely multifactorial. Perhaps the
availability of quality intensive care and gastroenterological spe-
cialists, as well as access to advanced diagnostic and therapeutic
procedures, contribute to improved outcomes at HV hospitals.
Intensive care specialists running intensive care units have been
previously associated with improved outcomes in critically ill
patients.21 Higher volumes may also lead to the development of
streamlined treatment protocols and processes of care, resulting in
improved outcomes based on the overall experience of the health
care team.
Several limitations of this study must be considered. This was a
retrospective study and has the associated constraints as a result of
the level of NIS data. The main outcome measure of this study was
in-hospital mortality. This may reflect a lower mortality rate com-
pared with studies using 30-day mortality rates as most patients
were probably discharged from hospital prior to the potential
death (if applicable). Our study used population-based data with
only limited information on patient and treatment factors, which
limits our evaluation of medical factors such as admission labo-
ratory tests (lactate dehydrogenase [LDH], white blood cell count,
glucose, aspartate aminotransferase [AST]) and treatment over
the first 48 hours (mechanical ventilation, antibiotic use, etc.).
Although the NIS represents the largest all-payer database of hos-
pital discharge records in the USA, there is no guarantee that our
cohort is representative of local demographics and medical prac-
tices, which may vary by state and community.
To our knowledge, this is the first study to show a significant
outcome benefit for acute pancreatitis at HV hospitals. The large
sample size and high number of covariates examined indicate that
our findings are, indeed, real. Few past studies have shown such a
volume benefit in a medical diagnosis.
Given the rising incidence and high treatment cost of acute
pancreatitis in the USA, our study suggests that referral of com-
plicated cases of acute pancreatitis to HV centres should be con-
sidered at the policy level. Future studies should endeavour to
elucidate compelling reasons for this outcome benefit, such as the
availability of critical care facilities and specialists, and the true
role of operative intervention.
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